|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,774 GBX | +0.71% |
|
+6.01% | +22.29% |
| 05:58pm | Gsk plc Announces Board Committee Changes | CI |
| 02:21pm | GSK : Receives a Buy rating from Bernstein | ZD |
May 27 (Reuters) - GSK:
* VIIV HEALTHCARE COMMITS TO GRANT VOLUNTARY LICENCE FOR PATENTS RELATING TO CABOTEGRAVIR LONG-ACTING FOR PREP TO MEDICINES PATENT POOL
* GSK - VIIV HEALTHCARE AND MPP ARE ACTIVELY NEGOTIATING VOLUNTARY LICENSING TERMS TO HELP WIDEN ACCESS TO INNOVATIVE HIV PREVENTION MEASURE
* GSK: COMMITMENT BUILDS ON A LONG-STANDING PARTNERSHIP BETWEEN VIIV HEALTHCARE AND MPP Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +22.29% | 90.07B | |
| +32.95% | 700B | |
| -4.97% | 358B | |
| +18.83% | 330B | |
| +3.54% | 287B | |
| +15.70% | 236B | |
| +6.68% | 202B | |
| -9.08% | 197B | |
| +6.70% | 161B | |
| -1.81% | 157B |
GSK PLC 
